Bayer Annual Report 2004
Science For A Better Life Annual Report Bayer Group Key Data Bayer Annual Report 2004 Bayer Group 2003 2004 Change € million in % Net sales 28,567 29,758 + 4.2 EBITDA1) 3,616 4,130 + 14.2 Operating result [EBIT] (1,119) 1,808 • Income (loss) before income taxes (1,994) 985 • Net income (loss) (1,361) 603 • Gross cash flow2) 2,864 3,210 + 12.1 Net cash flow3) 3,293 2,450 – 25.6 Stockholders’ equity 12,213 12,268 + 0.5 Total assets 37,445 37,804 + 1.0 Capital expenditures 1,739 1,275 – 26.7 Employees at year end 115,400 113,000 – 2.1 Personnel expenses 7,906 7,306 – 7.6 Research and development expenses 2,404 2,107 – 12.4 Bayer AG 2003 2004 Change in % Total dividend payment in € million 365 402 + 10.1 Dividend per share in € 0.50 0.55 + 10.0 1) EBITDA = operating result (EBIT) plus depreciation and amortization 2) Gross cash flow = operating result (EBIT) plus depreciation and amortization, minus income taxes, minus gains/plus losses on retirements of noncurrent assets, plus/minus changes in pension provisions 3) Net cash flow = cash flow from operating activities according to IAS 7 Ten-Year Financial Summary Bayer Annual Report 2004 Bayer Group 1995 1996 1997 1998 1999 € million Net sales 22,793 24,853 28,124 28,062 27,320 Sales outside Germany 80.5% 82.2% 83.9% 83.6% 84.3% Sales of foreign consolidated companies 63.4% 65.4% 67.0% 67.5% 68.3% Operating result [EBIT] 2,102 2,306 3,077 3,155 3,357 Income (loss) before income taxes 2,140 2,282 2,611 2,728 2,836 Income (loss) after taxes 1,238 1,405 1,509 1,615 2,018 Noncurrent assets 9,437
[Show full text]